Not applicableActive Not RecruitingNCT06886958What this trial is testingSpectral CT Protocol Optimization for Atherosclerotic Plaque CharacterizatIONWho this might be right forAtherosclerotic Disease IRCCS SYNLAB SDN 100
Not applicableStudy completedNCT02360137What this trial is testingAtherosclerotic Plaque Characteristics Associated With a Progression Rate of the Plaque in Carotids and a Risk of StrokeWho this might be right forCarotid Artery PlaqueCarotid Web University Hospital Ostrava 1,863
Post-approval studies (Phase 4)Active Not RecruitingNCT06249165What this trial is testingVictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart DiseaseWho this might be right forAtherosclerotic Cardiovascular Disease Duke University 130
Large-scale testing (Phase 3)Study completedNCT00799903What this trial is testingThe Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy TrialWho this might be right forAtherosclerosis GlaxoSmithKline 15,828
Not applicableStudy completedNCT01609725What this trial is testingPeriodontal Therapy in Coronary Artery PatientsWho this might be right forCardiovascular DiseasesAtheromaCoronary Artery Disease Federal University of Rio Grande do Sul 93
Large-scale testing (Phase 3)Looking for participantsNCT06930885What this trial is testingPolypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular DiseaseWho this might be right forAtherothrombotic DiseasesAtherosclerotic Cardiovascular Disease (ASCVD) Hospital do Coracao 7,713
Large-scale testing (Phase 3)Study completedNCT04807400What this trial is testingStudy in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced SupportWho this might be right forAtherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease Risk EquivelentsElevated Low Density Lipoprotein Cholesterol Novartis Pharmaceuticals 892
Large-scale testing (Phase 3)Study completedNCT05021835What this trial is testingZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and InflammationWho this might be right forCardiovascular RiskChronic Kidney DiseaseInflammation Novo Nordisk A/S 6,385
Large-scale testing (Phase 3)Study completedNCT06005597What this trial is testingStudy of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying TherapiesWho this might be right forDyslipidemiasHypercholesterolemiaFamilial Hypercholesterolemia+2 more NewAmsterdam Pharma 407
Not applicableLooking for participantsNCT07332468What this trial is testingDigital Remote Management for Care and Continuous Optimization Versus Usual Care to Reduce Risk of Atherosclerotic Cardiovascular Diseases (DigiCare-preASCVD)Who this might be right forAtherosclerotic Cardiovascular Diseases Beijing Anzhen Hospital 564
Large-scale testing (Phase 3)Study completedNCT01120405What this trial is testingCardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac SurgeryWho this might be right forElevated Cardiac RiskCoronary Arteries Disease Risk Air Liquide Santé International 600
Large-scale testing (Phase 3)Study completedNCT03400800What this trial is testingInclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein CholesterolWho this might be right forASCVDRisk Factor, CardiovascularElevated Cholesterol The Medicines Company 1,617
Not applicableLooking for participantsNCT06871514What this trial is testingEffectiveness of Decision Support for Cardiovascular Risk Management in People With Cardiovascular DiseaseWho this might be right forAtherosclerotic Cardiovascular DiseasesShared-decision Making dr.Frank L.J. Visseren 1,200
Large-scale testing (Phase 3)Looking for participantsNCT07000357What this trial is testingA Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First EventWho this might be right forCardiovascular Disease AstraZeneca 15,100
Large-scale testing (Phase 3)Study completedNCT02991118What this trial is testingEvaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular RiskWho this might be right forHypercholesterolemiaAtherosclerotic Cardiovascular Disease Esperion Therapeutics, Inc. 779
Not applicableStudy completedNCT04975503What this trial is testingRisk Factors in Young Middle Eastern Women With Cardiovascular DiseaseWho this might be right forCardiovascular DiseasesRisk Factors Jordan Collaborating Cardiology Group 627
Not applicableStudy completedNCT00689377What this trial is testingPrevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary PreventionWho this might be right forPeripheral Arterial Disease (PAD)Moderate Risk for Cardiovascular Disease (CVD) AstraZeneca 9,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07729475What this trial is testingA Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of Cardiovascular EventsWho this might be right forElevated Lipoprotein(a) Shenzhen Salubris Pharmaceuticals Co., Ltd. 120
Not applicableUnknownNCT06316453What this trial is testingProspective Assessment of Atherosclerotic Cardiovascular Disease (ASCVD) RiskWho this might be right forAtherosclerotic Cardiovascular Diseases (ASCVD) Advanced Education & Research Center 3,513
Not applicableNot Yet RecruitingNCT07355894What this trial is testingHealth Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)Who this might be right forAtherosclerotic Cardiovascular Disease (ASCVD)Coronary Artery Calcification Stanford University 120,000